The outlook for the hospice M&A market is equal parts promising and potentially turbulent, with regulatory and reimbursement pressures among the challenges on investors’ radar. Hospice merger and acquisition activity has seen a slump compared to previous record-breaking years. Interest in the space isn’t anticipated to abate anytime soon, but hospice transactions are facing greater obstacles related to regulatory oversight and profitability, according to Mark Kulik, senior managing director at The Braff Group.
Read the full article: Hospice Compliance, Reimbursement Pressures on M&A ‘Higher than Ever Before’ //
Source: https://hospicenews.com/2024/08/16/hospice-compliance-reimbursement-pressures-on-ma-higher-than-ever-before/